
Joseph H. Murray
Examiner (ID: 1129)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1613, 1626 |
| Total Applications | 346 |
| Issued Applications | 321 |
| Pending Applications | 11 |
| Abandoned Applications | 14 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5581348
[patent_doc_number] => 20090176694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Reagents and Methods for Smooth Muscle Therapies'
[patent_app_type] => utility
[patent_app_number] => 12/101691
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15525
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176694.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101691 | Reagents and methods for smooth muscle therapies | Apr 10, 2008 | Issued |
Array
(
[id] => 7527426
[patent_doc_number] => 08044018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Reagents and methods for smooth muscle therapies'
[patent_app_type] => utility
[patent_app_number] => 12/101710
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 15518
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101710
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101710 | Reagents and methods for smooth muscle therapies | Apr 10, 2008 | Issued |
Array
(
[id] => 5446923
[patent_doc_number] => 20090048149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Antagonists of the bradykinin B1 receptor'
[patent_app_type] => utility
[patent_app_number] => 12/082395
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25850
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048149.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082395 | Antagonists of the bradykinin B1 receptor | Apr 8, 2008 | Abandoned |
Array
(
[id] => 4682790
[patent_doc_number] => 20080249016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Use of GLP-2 in a combination treatment for bone-related disorders'
[patent_app_type] => utility
[patent_app_number] => 12/082277
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 37135
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082277
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082277 | Use of GLP-2 in a combination treatment for bone-related disorders | Apr 8, 2008 | Abandoned |
Array
(
[id] => 8446297
[patent_doc_number] => 08288351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Antagonists of the bradykinin B1 receptor'
[patent_app_type] => utility
[patent_app_number] => 12/082224
[patent_app_country] => US
[patent_app_date] => 2008-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25884
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12082224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082224 | Antagonists of the bradykinin B1 receptor | Apr 7, 2008 | Issued |
Array
(
[id] => 5564599
[patent_doc_number] => 20090137452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Antagonists of the bradykinin B1 receptor'
[patent_app_type] => utility
[patent_app_number] => 12/082219
[patent_app_country] => US
[patent_app_date] => 2008-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25843
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137452.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082219 | Antagonists of the bradykinin B1 receptor | Apr 7, 2008 | Issued |
Array
(
[id] => 4954469
[patent_doc_number] => 20080187493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Peptide-Based Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/053829
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11336
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187493.pdf
[firstpage_image] =>[orig_patent_app_number] => 12053829
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/053829 | Peptide-based compounds | Mar 23, 2008 | Issued |
Array
(
[id] => 6492841
[patent_doc_number] => 20100093640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'ACE-INHIBITORY PEPTIDES FROM WHEY AND METHODS FOR PROVIDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/529566
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8158
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529566 | ACE-INHIBITORY PEPTIDES FROM WHEY AND METHODS FOR PROVIDING THE SAME | Mar 5, 2008 | Abandoned |
Array
(
[id] => 6275254
[patent_doc_number] => 20100256061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'GASTRIN COMPOUND FOR DIABETES TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/529601
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256061.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529601
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529601 | GASTRIN COMPOUND FOR DIABETES TREATMENT | Feb 28, 2008 | Abandoned |
Array
(
[id] => 6454132
[patent_doc_number] => 20100105628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE'
[patent_app_type] => utility
[patent_app_number] => 12/526011
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8612
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526011 | REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE | Feb 13, 2008 | Abandoned |
Array
(
[id] => 4808272
[patent_doc_number] => 20080171850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents'
[patent_app_type] => utility
[patent_app_number] => 11/969174
[patent_app_country] => US
[patent_app_date] => 2008-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25031
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171850.pdf
[firstpage_image] =>[orig_patent_app_number] => 11969174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/969174 | Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents | Jan 2, 2008 | Abandoned |
Array
(
[id] => 4779651
[patent_doc_number] => 20080287649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Methods for the synthesis of cyclic peptides'
[patent_app_type] => utility
[patent_app_number] => 12/004265
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10485
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004265
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004265 | Methods for the synthesis of cyclic peptides | Dec 19, 2007 | Abandoned |
Array
(
[id] => 5337859
[patent_doc_number] => 20090054323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Specific Binding Agents of Human Angiopoietin-2'
[patent_app_type] => utility
[patent_app_number] => 11/952738
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 48567
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952738
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952738 | Specific binding agents of human angiopoietin-2 | Dec 6, 2007 | Issued |
Array
(
[id] => 4704203
[patent_doc_number] => 20080063727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 11/979148
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6993
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11979148
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/979148 | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | Oct 30, 2007 | Abandoned |
Array
(
[id] => 8282893
[patent_doc_number] => 08216995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Botulinum toxin treatments'
[patent_app_type] => utility
[patent_app_number] => 11/932524
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4301
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/932524 | Botulinum toxin treatments | Oct 30, 2007 | Issued |
Array
(
[id] => 4675683
[patent_doc_number] => 20080213312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'BOTULINUM TOXIN TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 11/932435
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4302
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11932435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/932435 | BOTULINUM TOXIN TREATMENTS | Oct 30, 2007 | Abandoned |
Array
(
[id] => 6220052
[patent_doc_number] => 20100055147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'ANGIOTENSIN (1-7) ELUTING STENT'
[patent_app_type] => utility
[patent_app_number] => 12/447415
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6999
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12447415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/447415 | ANGIOTENSIN (1-7) ELUTING STENT | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4846563
[patent_doc_number] => 20080182971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 11/876258
[patent_app_country] => US
[patent_app_date] => 2007-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11180
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182971.pdf
[firstpage_image] =>[orig_patent_app_number] => 11876258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/876258 | PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS | Oct 21, 2007 | Abandoned |
Array
(
[id] => 4880373
[patent_doc_number] => 20080153756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Novel Peptides and Methods for the Treatment of Inflammatory Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/874356
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14195
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874356
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874356 | Novel Peptides and Methods for the Treatment of Inflammatory Disorders | Oct 17, 2007 | Abandoned |
Array
(
[id] => 4879285
[patent_doc_number] => 20080152668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Thymosin Alpha 1 Peptide/Polymer Conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/865816
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2754
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20080152668.pdf
[firstpage_image] =>[orig_patent_app_number] => 11865816
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/865816 | Thymosin Alpha 1 Peptide/Polymer Conjugates | Oct 1, 2007 | Abandoned |